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Abstract
Background: We highlight the orbital manifestations of acute myeloid leukemia and the role of
peripheral blood smear in the diagnosis of these cases. A total of 12 patients who presented with
proptosis and were subsequently diagnosed to have acute myeloid leukemia based on incision
biopsy or peripheral blood smear were included in the study.
Results: A retrospective review of all cases of acute myeloid leukemia presenting to the Orbital
clinic was performed. The age at presentation, gender, presenting features, duration of symptoms
and fundus features were noted. In addition the temporal relationship of the orbital disease to the
diagnosis of leukemia, laterality, location of the orbital mass, imaging features and the diagnostic
tools used to diagnose leukemia were noted. The median age at presentation was 6 years. The
male: female ratio was 0.7:1. None of these patients had been diagnosed earlier as having acute
myeloid leukemia. The presenting features included proptosis in all patients, orbital mass in 5
(41.7%), visual symptoms in 2 (16.7%) and subconjunctival hemorrhage in one patient (8.3%). A
diagnosis of acute myeloid leukemia was established by incision biopsy in 4 patients, subsequently
confirmed by peripheral blood smear testing and bone marrow biopsy in 2 patients which revealed
the presence of systemic involvement. Imprint smears of the biopsy identified blasts in 2 of 4 cases.
In 8 patients presenting with ocular manifestations, diagnosis was established by peripheral blood
smear examination alone which revealed a diagnosis of acute myeloid leukemia.
Conclusion: A peripheral blood smear should be performed in all cases of sudden onset proptosis
or an orbital mass in children and young adults along with an orbital biopsy. It can always be
complemented with a bone marrow biopsy especially in cases of aleukemic leukemia or when the
blood smear is inconclusive.
Background
Acute myeloid leukemia (AML) accounts for nearly 15%
of all leukemias in children [1]. The leukemic cells can
infiltrate any extramedullary site, tumorous accumula-
tions within soft tissues and bones being labeled as gran-
ulocytic sarcomas. Granulocytic sarcoma (GS) or
extramedullary leukemic deposits is an unusual manifes-
tation of AML, accounting for about 3% of cases of AML
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[2]. Allen Burns was the first to describe it in 1811 as a
green tumor involving the orbit [2]. Due to their charac-
teristic green color, King in 1853 named these tumors as
chloromas (greek 'chloros' meaning green) [3]. Exposure
of the myeloperoxidase enzyme present in these tumor
cells to ultraviolet light is responsible for this green colour
[2]. However nearly one third of the tumors do not exhibit
this phenomenon. Rappaport suggested the name granu-
locytic sarcoma considering the association of these
tumors to leukemia [4]. Granulocytic sarcoma has also
been known by many other names including myeloblast-
oma, myelocytomas, myelosarcoma, chloroleukemia [5].
The natural history of these tumors can be variable. This
tumor can present prior to, concomitantly or even during
remission of systemic leukemia [5,6]. Diagnosis can be
challenging if there is an orbital GS in a patient without
any known hematological malignancy. Alternatively the
tumor can develop in an established case of systemic
leukemia. Extramedullary leukemic deposits can be seen
with different forms of myeloid leukemia including acute
myelogenous leukemia, chronic myelogeneous leukemia
with or without blast crisis and other myeloproliferative
disorders. In cases where the orbital tumor is the initial
manifestation, peripheral blood and bone marrow
involvement usually occurs within a year of the occur-
rence of orbital disease [2].
In this report we describe 12 cases of acute myeloid leuke-
mia that presented to the ophthalmology clinic with
proptosis and a diagnosis of AML was subsequently made
by a peripheral blood smear or incision biopsy. This case
series emphasizes the importance of these simple yet val-
uable investigations in making a diagnosis of this grave
systemic malignancy.
Results
Twelve cases of acute myeloid leukemia had presented
with proptosis. None of these patients had been diag-
nosed earlier as having acute myeloid leukemia. The
median age at presentation was 6 years (mean 8.6 years;
range 10 months – 17 years), (Table 1). There were seven
females and five males. The presenting features included
proptosis in all patients, orbital mass in 5 (41.7%), visual
symptoms in 2 (16.7%) and subconjunctival hemorrhage
in one patient (8.3%). The median duration of symptoms
before presentation was 4 weeks (mean 7 weeks; range 2
weeks to 20 weeks). Fundus manifestations in the form of
retinal pale centered hemorrhages or subhyaloid hemor-
rhages were present in 4 (33.3%) patients and disc edema
in 2 (16.7%) patients.
Ocular features were bilateral in 4 patients, right eye was
involved in 4 and the left eye involved in 4 patients
respectively. Lymphadenopathy was present in 5 patients,
the submandibular lymph nodes being the most com-
monly involved, (Table 1). An orbital mass was palpable
in 11 patients, commonly located superior or superotem-
porally.
A diagnosis of acute myeloid leukemia was established by
incision biopsy in 4 patients, 2 of whom further under-
went peripheral blood smear testing and bone marrow
biopsy which revealed the presence of systemic involve-
ment. Imprint smears of the fresh tissues performed in 2
cases showed the presence of large blasts with scant cyto-
plasm and a large nucleus with 2–3 nucleoli and fine
chromatin pattern. The smears were useful in confirming
a hematopoeitic malignancy and in ruling out other
tumors. In 8 patients diagnosis was established by periph-
eral blood smear examination alone which revealed a
diagnosis of acute myeloid leukemia, (Table 2). Presence
of more than 30% blasts in the peripheral smear was con-
sidered diagnostic of acute myeloid leukemia. Blasts were
seen as large cells (2–3 times the size of a mature lym-
phocyte, with a high nuclear/cytoplasmic ratio, a round to
indented nucleus with fine nuclear chromatin and 1–3
nucleoli. Myeloperoxidase positivity was noted in all 4
incision biopsy specimens. Once the diagnosis was estab-
lished all the patients were referred to a pediatric oncolo-
gist for further management and were not followed up by
us.
Discussion
Granulocytic sarcoma is a rare presentation of acute mye-
loid leukemia. Even though it can present from infancy to
old age, it most commonly affects children and young
adults. In our series the median age at presentation was 6
years. Zimmerman reported a median age of 7 years
(range 1–61 years) and Stockl et al 8.8 years in their stud-
ies [2,6]. Though previous studies have noted a slight
male preponderance with a ratio of about 1.5:1, we had
more females affected than males [5,6]. The incidence of
this tumor is more in African, Asian, Latin American and
Middle Eastern children [2]. Ghose et al in their study of
86 Indian children with AML, reported orbital masses in
9.3% cases [7]. In a study of Turkish children with acute
myelomonocytic leukemia, granulocytic sarcoma was
reported to be present in 20 of the 56 (36%) children [8].
Templeton in his study of orbital tumors in Africa noted
that the second most common orbital malignancy in chil-
dren after Burkitt's lymphoma was granulocytic sarcoma
[9].
Granulocytic sarcoma is thought to originate in the bone
marrow and the cells are believed to spread via the Haver-
sian canals to collect in the subperiosteum and form a soft
tissue mass [1]. They more commonly affect the skeletal
system, commonly the ligaments or periosteum. In cases
with head and neck involvement they commonly affectJournal of Hematology & Oncology 2009, 2:4 http://www.jhoonline.org/content/2/1/4
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the orbit or epidural space [10]. These tumors most com-
monly affect the skull, orbit, paranasal sinuses, spine, ribs,
sacrum and sternum, involvement being related to the
active hematopoeisis at these sites [1]. It can also involve
the lymph nodes, skin and kidney [2]. In the autopsy
study from Japan by Liu et al, bone was the most common
site of involvement [11].
In our series the most common presenting features were
an orbital mass and proptosis. Various other studies have
described proptosis as the most common presenting fea-
ture [9-11], (Table 3). Zimmerman and Font noted that
88% of their patients presented with proptosis [6]. Sud-
den onset of bilateral proptosis with extraocular muscle
infiltration has also been reported [12]. We also noted the
presence of retinal and preretinal hemorrhages. The pres-
ence of the characteristic pale centered hemorrhages
should be viewed with a high index of suspicion of acute
myeloid leukemia. Granulocytic sarcoma can also present
as ptosis, lacrimal gland involvement, conjunctival mass,
iridic and diffuse uveal involvement [2,5].
The onset of orbital granulocytic sarcoma in relation to
systemic AML can be variable. The orbit can be involved
even before the bone marrow and peripheral blood show
features of the malignancy. In Zimmerman's series, in
88% of the cases the orbital granulocytic sarcoma devel-
oped before the development of systemic leukemia [6].
Various reports have described the occurrence of orbital
GS before the development of systemic leukemia [2,6,8].
Table 1: Ocular manifestations, patient details, laterality, lymph node involvement and orbital mass location
No Age Sex Presenting 
features
Duration of 
symptoms
Fundus 
features
Laterality Lymph nodes 
involved
Exophthalmometry 
(mm of proptosis)
Location of mass 
(palpation)
1 12 years Female Proptosis 4 weeks Pale centred 
hemorrhages, 
preretinal 
hemorrhage
Left SMN bilateral 4 mm Superior
2 5 years Female Proptosis, 
orbital mass
4 weeks Normal Bilateral SMN, PAN, 
ACN bilateral
- Superior
3 13 years Male Proptosis, 
orbital mass
8 weeks Retinal 
hemorrhages
Right PAN 9 Superotemporal
4 15 years Male Proptosis 4 weeks Normal Bilateral Right SMN, 
ACN; left 
PAN, SMN
3 Superior
5 4 years Female Proptosis, 
orbital mass
4 weeks Retinal 
hemorrhages, 
disc edema
Bilateral - 5 Superotemporal
6 10 years Female Proptosis, 
orbital mass, 
subconjunctiv
al hemorrhage
20 weeks Subhyaloid 
hemorrhage
Left - 8 Superotemporal
7 1 years Female Proptosis 2 weeks Normal Right - - -
8 6 years Female Proptosis 2 weeks Normal Left - 8 Superotemporal
9 4 years Male Proptosis 2 weeks Normal Left - - Superomedial
10 17 years Male Proptosis, 
blurred vision
12 weeks Normal Right - 5 Superomedial
11 10 months Female Proptosis, 
orbital mass
8 weeks Normal Both - - Superior
12 9 years Male Proptosis, 
diminution of 
vision
8 weeks Disc edema Right - 11 Superotemporal
SMN = submandibular lymph nodes; PAN = preauricular lymph nodes; ACN = anterior cervical lymph nodes.Journal of Hematology & Oncology 2009, 2:4 http://www.jhoonline.org/content/2/1/4
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Systemic features usually develop within a year in these
patients. In Zimmerman's series, 12 of the 29 developed
signs of leukemia within 2 months[6]. Stockl et al in their
series reported that 2 of their 7 patients had orbital lesions
and the systemic disease simultaneously[2]. In our case
series all the patients were noted to have orbital disease
and systemic involvement concurrently. Cavdar et al in
their series from Turkey reported that 19 of the 20 chil-
dren had abnormal blood counts at initial presenta-
tion[8]. Cavdar et al biopsied only 12 of his 33 patients
and Bidar et al biopsied only 2 of 27 patients, both of
whom had presented with orbital disease prior to diagno-
sis of systemic malignancy[13]. We had 4 patients who
underwent an incision biopsy at the first instance and this
led to the diagnosis of systemic leukemia. These were
patients who were seen before the year 2000. In 8 patients
we established the diagnosis solely based on the periph-
eral smear, as after the year 2000, we subjected all children
presenting with proptosis to a peripheral blood smear as
part of the routine workup. If the diagnosis can be estab-
lished on a non invasive test like a peripheral blood
smear, one can avoid surgical intervention. In our series
the median duration of symptoms was 4 weeks. In
Cavdar's series the median duration of orbital symptoms
was 8 weeks before the diagnosis of leukaemia[8].
The diagnosis of this tumor can be challenging especially
when there are no signs of systemic leukemia. In the pres-
Table 2: Diagnostic tests
No Incision biopsy Peripheral blood smear Bone marrow Myeloperoxidase
1 - + Positive -
2+ - - +
3- + - -
4- + - -
5 + + Positive +
6- + - -
7 + + Positive +
8+ - - +
9- + - -
10 - + - -
11 - + Positive -
12 - + Positive -
Table 3: Summary of major case series of orbital leukemic tumors
Study Number of cases Age(years) Male/Female ratio Orbital disease on initial presentation
Stockl et al2 7 8.8 2.5:1 4/7
Zimmerman and Font6 33 7 1.5:1 29/33
Cavdar et al8 33 7.3 4.5:1 32/33
Bidar et al13 27 8 2.4:1 4/27
Current study 12 8.8 0.7:1 12/12Journal of Hematology & Oncology 2009, 2:4 http://www.jhoonline.org/content/2/1/4
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ence of systemic malignancy, a peripheral blood smear or
a bone marrow biopsy may provide useful clues to the
diagnosis. Zimmerman et al reported that the most com-
mon misdiagnosis was malignant lymphoma[6]. How-
ever orbital lymphomas are more common in adults and
any such diagnosis in a child should be reinvestigated to
rule out granulocytic sarcoma[5]. This tumor can also be
confused with rhabdomyosarcomas, neuroblastomas and
Burkitt's lymphoma. Neuroblastomas and Ewing's sar-
coma usually cause more bony destruction[1,7]. Clinical
features are not specific to aid in the diagnosis. However
one constant feature we found was the superior or super-
otemporal location of the tumor in 11 of 12 patients.
Radiological features are again not characteristic. The
computed tomography (CT) findings have been described
as a focal homogenously enhancing lesion with well-
defined margins, usually isodense to muscle [1]. The
tumors can mould to the surrounding structures. It is usu-
ally confined to the orbit and spread to the paranasal
sinuses is rare. On T2-weighted MRI it is isointense to
white matter, muscle and bone marrow, while on T1-
weighted MRI it is slightly hyperintense[1,5]. The tumor
shows a marked contrast enhancement to gadopentetate
dimeglumine[3,11].
Evaluation of the peripheral smear is an invaluable tool in
the diagnosis if the systemic manifestations are already
present as in our series. Previous reports have highlighted
the role of this inexpensive investigation in all cases of
childhood proptosis[7,12]. The peripheral smear reveals
the presence of immature blast cells. The total leucocyte
count is usually high with a relative neutropenia. Bone
marrow examination and flow cytometry should be rou-
tinely performed to confirm the diagnosis. Squash and
Histopathology of orbital mass showing a round cell tumor  infiltrating the orbital fat tissues (hematoxylin & eosin, × 400) Figure 4
Histopathology of orbital mass showing a round cell 
tumor infiltrating the orbital fat tissues (hematoxylin 
& eosin, × 400).
CT scan axial view revealed a diffuse soft tissue mass involv- ing the left superotemporal orbit Figure 2
CT scan axial view revealed a diffuse soft tissue mass 
involving the left superotemporal orbit.
A 6 year old girl presented with left eye proptosis and down- ward displacement of the globe Figure 1
A 6 year old girl presented with left eye proptosis 
and downward displacement of the globe. A firm mass 
was palpable in the superotemporal quadrant of the left 
orbit.
CT scan coronal view showed the superior and lateral rectus  muscles mass could not be differentiated from the mass Figure 3
CT scan coronal view showed the superior and lat-
eral rectus muscles could not be differentiated from 
the mass.Journal of Hematology & Oncology 2009, 2:4 http://www.jhoonline.org/content/2/1/4
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imprint cytology could aid in diagnosis of this hemato-
logic malignancy [13]. Though a definite distinction can-
not be made from large cell lymphoma, the presence of
singly scattered blasts, with relatively abundant pale stain-
ing cytoplasm, 2–3 nucleoli, cytoplasmic granules and
Auer rods could help in suggesting extramedullary leuke-
mic deposits [14]. Romanowsky stained (Giemsa) air-
dried smears are useful in interpreting the hematologic
lesions of leukemia and lymphoma. Immunocytochemis-
try or immunohistochemistry using antibody against
myeloperoxidase could confirm the diagnosis. Hematox-
ylin eosin stain reveals the presence of cells of myeloid lin-
eage with eosinophilic cytoplasmic granules. Auer rods
may be absent in routine Romanowsky stained speci-
mens. Mc Carty et al have reported that sudanophilic
(Sudan black B) and myeloperoxidase staining can dem-
onstrate fusiform and spindle shaped particles, phi bodies
and rods on light microscopy in these patients [15]. The
diagnosis is also dependant on the amount of granulo-
cytic differentiation. Niemen et al noted that poorly differ-
entiated tumors are diagnosed correctly 47% of the time
and well differentiated tumors 54% of the time[16]. The
Leder stain (naphtol-AS-O-chlororacetate esterase) meas-
ures the esterase activity and can be performed on paraffin
stained slides. Diagnosis can be established in nearly 75%
of the cases using this stain[2]. Immunohistochemical
stains using antilysozyme antibody has been reported to
be positive in upto 90% of the cases. Stockl et al reported
MAC387 positivity was present in all their seven cases of
granulocytic sarcoma[2].
The prognosis for patients with granulocytic sarcoma
depends on the course of the underlying systemic malig-
nancy[1,5]. Initiating treatment early can improve the
prognosis and outcome. Chemotherapy is the mainstay of
treatment. The presence of orbital granulocytic sarcoma
does not significantly alter the survival in patients with
AML[5]. The rate of remission following chemotherapy
also does not seem to be significantly affected due to the
presence of granulocytic sarcoma.
Conclusion
Granulocytic sarcoma is a rare cause of childhood propto-
sis. A peripheral blood smear should be performed in all
cases of sudden onset proptosis or an orbital mass in chil-
dren and young adults. It should be complemented with
The imprint smears of the biopsy show clumps of large  round cells appearing like blasts (Giemsa, × 400) Figure 6
The imprint smears of the biopsy show clumps of 
large round cells appearing like blasts (Giemsa, × 
400).
The tumor cells are strongly immunoreactive to myeloper- oxidase (DAB, × 400) Figure 5
The tumor cells are strongly immunoreactive to 
myeloperoxidase (DAB, × 400).
Higher magnification of the same shows the presence of  Auer rod in the cytoplasm of cells (Giemsa, × 1000) Figure 7
Higher magnification of the same shows the pres-
ence of Auer rod in the cytoplasm of cells (Giemsa, × 
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a bone marrow biopsy especially in cases of aleukemic
leukemia and biopsy of the orbital lesion especially in
cases where the blood smear is inconclusive. The use of
special stains and immunohistochemical techniques can
help further in establishing the diagnosis in orbital GS.
Early treatment and diagnosis is the key to prolonging the
survival in this aggressive malignancy.
Methods
A retrospective review of the records of all the patients in
the ophthalmic pathology service was performed from
January 1998 to September 2008. There were 13 cases of
leukemia involving the eye or the orbit (for examples and
further detail, see figures 1, 2, 3, 4, 5, 6, 7). One of them
had only intraocular manifestations and was excluded
from this study. Twelve cases with orbital manifestations
were included in the case series.
Medical records of these patients were reviewed for the
demographic details, clinical presenting features and radi-
ologic findings. Diagnosis was established by peripheral
blood smear or incision biopsy and in addition some
cases underwent bone marrow biopsy. The peripheral
blood smear examination and bone marrow cytology was
done by an experienced pathologist (GKV) as per the FAB
classification. In cases that underwent incisional biopsy,
intraoperative diagnosis was attempted by squash and
imprint cytology. Myeloperoxidase staining was per-
formed on the smears or biopsy specimens. All the
patients were referred to a pediatric oncologist for further
management.
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